New pill for postpartum depression a vital breakthrough

New pill for postpartum depression a vital breakthrough
One in seven new mothers develop the serious medical condition. (Image: Getty)
Bloomberg
By Lisa Jarvis The landmark approval in the US of the first pill for postpartum depression offers an important new treatment for the 1 in 7 new mothers who develop the condition. Suicide is a leading cause of maternal mortality in the US. And yet on its own, the new drug – promising as it is – isn’t enough. Consider that as many as half of women with postpartum depression go undiagnosed.Nonetheless, the new pill is a remarkable breakthrough, and one of several encouraging recent developments in women’s health &...

More Health

Minister's $200m tobacco tax cut bypasses Cabinet requirements
Policy

Minister's $200m tobacco tax cut bypasses Cabinet requirements

Researchers say there's more evidence to support the repealed Smokefree policies.

Blood cancer clinical trials starting at Wellington Hospital
News in Brief

Blood cancer clinical trials starting at Wellington Hospital

The phase 2 trial will test the Malaghan Institute's groundbreaking therapy.

Staff reporters 25 Jul 2024
Commissioner replaces Te Whatu Ora’s board
Policy

Commissioner replaces Te Whatu Ora’s board

Lester Levy to be new health czar.

Jem Traylen 22 Jul 2024
Health NZ: fewer billion-dollar hospital projects, more staging
Infrastructure

Health NZ: fewer billion-dollar hospital projects, more staging

The centralised agency wants to change how NZ delivers health infrastructure.

Oliver Lewis 18 Jul 2024